RhoA enhances osteosarcoma resistance to MPPa-PDT via the Hippo/YAP signaling pathway
{{output}}
Background: Osteosarcoma (OS) is the most prevalent primary bone malignancy affecting adolescents, yet the emergence of chemoradiotherapeutic resistance has limited efforts to cure affected patients to date. Pyropheophorbide-α m... ...